Cargando…

Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies

BACKGROUND: Resident stem and progenitor cells have been identified in the lung over the last decade, but isolation and culture of these cells remains a challenge. Thus, although these lung stem and progenitor cells provide an ideal source for stem-cell based therapy, mesenchymal stem cells (MSCs) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinh, Phuong-Uyen C., Cores, Jhon, Hensley, M. Taylor, Vandergriff, Adam C., Tang, Junnan, Allen, Tyler A., Caranasos, Thomas G., Adler, Kenneth B., Lobo, Leonard J., Cheng, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493087/
https://www.ncbi.nlm.nih.gov/pubmed/28666430
http://dx.doi.org/10.1186/s12931-017-0611-0
_version_ 1783247446125576192
author Dinh, Phuong-Uyen C.
Cores, Jhon
Hensley, M. Taylor
Vandergriff, Adam C.
Tang, Junnan
Allen, Tyler A.
Caranasos, Thomas G.
Adler, Kenneth B.
Lobo, Leonard J.
Cheng, Ke
author_facet Dinh, Phuong-Uyen C.
Cores, Jhon
Hensley, M. Taylor
Vandergriff, Adam C.
Tang, Junnan
Allen, Tyler A.
Caranasos, Thomas G.
Adler, Kenneth B.
Lobo, Leonard J.
Cheng, Ke
author_sort Dinh, Phuong-Uyen C.
collection PubMed
description BACKGROUND: Resident stem and progenitor cells have been identified in the lung over the last decade, but isolation and culture of these cells remains a challenge. Thus, although these lung stem and progenitor cells provide an ideal source for stem-cell based therapy, mesenchymal stem cells (MSCs) remain the most popular cell therapy product for the treatment of lung diseases. Surgical lung biopsies can be the tissue source but such procedures carry a high risk of mortality. METHODS: In this study we demonstrate that therapeutic lung cells, termed “lung spheroid cells” (LSCs) can be generated from minimally invasive transbronchial lung biopsies using a three-dimensional culture technique. The cells were then characterized by flow cytometry and immunohistochemistry. Angiogenic potential was tested by in-vitro HUVEC tube formation assay. In-vivo bio- distribution of LSCs was examined in athymic nude mice after intravenous delivery. RESULTS: From one lung biopsy, we are able to derive >50 million LSC cells at Passage 2. These cells were characterized by flow cytometry and immunohistochemistry and were shown to represent a mixture of lung stem cells and supporting cells. When introduced systemically into nude mice, LSCs were retained primarily in the lungs for up to 21 days. CONCLUSION: Here, for the first time, we demonstrated that direct culture and expansion of human lung progenitor cells from pulmonary tissues, acquired through a minimally invasive biopsy, is possible and straightforward with a three-dimensional culture technique. These cells could be utilized in long-term expansion of lung progenitor cells and as part of the development of cell-based therapies for the treatment of lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0611-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5493087
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54930872017-06-30 Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies Dinh, Phuong-Uyen C. Cores, Jhon Hensley, M. Taylor Vandergriff, Adam C. Tang, Junnan Allen, Tyler A. Caranasos, Thomas G. Adler, Kenneth B. Lobo, Leonard J. Cheng, Ke Respir Res Research BACKGROUND: Resident stem and progenitor cells have been identified in the lung over the last decade, but isolation and culture of these cells remains a challenge. Thus, although these lung stem and progenitor cells provide an ideal source for stem-cell based therapy, mesenchymal stem cells (MSCs) remain the most popular cell therapy product for the treatment of lung diseases. Surgical lung biopsies can be the tissue source but such procedures carry a high risk of mortality. METHODS: In this study we demonstrate that therapeutic lung cells, termed “lung spheroid cells” (LSCs) can be generated from minimally invasive transbronchial lung biopsies using a three-dimensional culture technique. The cells were then characterized by flow cytometry and immunohistochemistry. Angiogenic potential was tested by in-vitro HUVEC tube formation assay. In-vivo bio- distribution of LSCs was examined in athymic nude mice after intravenous delivery. RESULTS: From one lung biopsy, we are able to derive >50 million LSC cells at Passage 2. These cells were characterized by flow cytometry and immunohistochemistry and were shown to represent a mixture of lung stem cells and supporting cells. When introduced systemically into nude mice, LSCs were retained primarily in the lungs for up to 21 days. CONCLUSION: Here, for the first time, we demonstrated that direct culture and expansion of human lung progenitor cells from pulmonary tissues, acquired through a minimally invasive biopsy, is possible and straightforward with a three-dimensional culture technique. These cells could be utilized in long-term expansion of lung progenitor cells and as part of the development of cell-based therapies for the treatment of lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0611-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-30 2017 /pmc/articles/PMC5493087/ /pubmed/28666430 http://dx.doi.org/10.1186/s12931-017-0611-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dinh, Phuong-Uyen C.
Cores, Jhon
Hensley, M. Taylor
Vandergriff, Adam C.
Tang, Junnan
Allen, Tyler A.
Caranasos, Thomas G.
Adler, Kenneth B.
Lobo, Leonard J.
Cheng, Ke
Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title_full Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title_fullStr Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title_full_unstemmed Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title_short Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
title_sort derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493087/
https://www.ncbi.nlm.nih.gov/pubmed/28666430
http://dx.doi.org/10.1186/s12931-017-0611-0
work_keys_str_mv AT dinhphuonguyenc derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT coresjhon derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT hensleymtaylor derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT vandergriffadamc derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT tangjunnan derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT allentylera derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT caranasosthomasg derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT adlerkennethb derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT loboleonardj derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies
AT chengke derivationoftherapeuticlungspheroidcellsfromminimallyinvasivetransbronchialpulmonarybiopsies